In the current analysis, we found that a selective alpha 1 blocker (doxazosin) may be significantly associated with a reduced occurrence of postoperative hypoglycemia after pheochromocytoma surgery. This evidence concerns the gene PSMA6 and hereditary pheochromocytoma-paraganglioma.